Home - Zorgaanbod - Artsen - Dr. Eleni Tsiaousi

Eleni Tsiaousi

Secretariaat : 014/71 27 57
Afspraak via : 014/71 20 53 of 014/71 27 57

Extra informatie

Hepatologie, IBD

Bijzondere interesses

  • Diagnostische en therapetische endoscopieen (colonoscopies, gastroscopies, poliepectomies, plaatsing van stents, varices banding…)
  • Behandeling van hemorroiden met Infra Rood, sclerotherapie, banding en Injecties met Botox.
  • Behandeling van acute en chronische digestieve bloedingen (Argon laser, injecties met Adrenaline, clipping)
  • Behandeling van patienten met IBD (colitis ulcerosa en ziekte van Crohn)
  • Hepatologie (NASH, NAFLD, ethylhepatitis, virale hepatitis, PBC, AIH…)
  • Echografie van het abdomen
  • ERCP (basiskennis)
  • Algemene Inwendige ziekten.
  • Oncologie

Behaalde certificaten, wetenschappelijke publicaties, bijscholingen

  1. Malnutrition in end stage liver disease. Tsiaousi, A. Hatzitolios, S. Trygonis, C. Savopoulos. J Gastroenterol Hepatol 2008; 24(3):527-533
  2. Acute necrotizing pancreatitis caused by atheromatous embolization during Percutaneous Transcatheter Coronary Angioplasty (PTCA).C. Trygonis, E. Tsiaousi, S.E.Miliaras  Annals of Gastroenterology 2008; 21(2): 127-129.
  3. A Case of Churg-Strauss Syndrome Revealed by Eosinophilic Gastroenteritis. Giouleme O, Tsiaousi E, Theodoridis A, Karabatsou S, Tzioufa V, Koliouskas D. Dig Dis Sci. 2009; 54(1):174-7.
  4. High prevalence of dementia and cognitive impairment in indigenous Australians. Kountouras J, Gavalas E, Boziki M, Zavos C, Deretzi G, Grigoriadis N, Tsiaousi E, Katsinelos P, Chatzopoulos D, Tzilves D, Kouklakis G. Neurology. 2009 11;73(6):487; author reply 487-8.
  1. The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. Polyzos S, Kountouras J, Zavos C, Tsiaousi E. Diabetes Obes Metab. 2010 12(5):365-83.
  1. Retroperitoneal subdiaphragmatic bronchogenic cyst in an adult female. Trygonis, E. Tsiaousi, S. Miliaras, D. Miliaras, C. Trygonis. Hellenic Journal of Surgery 2010; 82: 2.
  1. 4,4′-Methylenedianiline-induced hepatitis in an industrial worker: Case report and review of the literature. Giouleme O, Karabatsou S, Hytiroglou P, Xanthis A, Tsiaousi E, Katsaros M, Koliouskas D. Hum Exp Toxicol. 2011 Jul;30(7):762-7.
  2. Neuroprotection in glaucoma: is there a future role of Helicobacter pylori eradication? Kountouras J, Zavos C, Deretzi G, Polyzos SA, Gavalas E, Tsiaousi E, Giartza-Taxidou E, Chatzopoulos D, Michael S, Tsarouchas G. Exp Eye Res. 2011;92(5):436-8.
  3. Autologous haematopoietic stem cell transplantation in a patient with refractory Crohn’s disease. Kountouras J, Sakellari I, Tsarouchas G, Tsiaousi E, Michael S, Zavos C, Anastasiadou K, Stergiopoulos C, Anagnostopoulos A. J Crohns Colitis. 2011;5(3):275-6.
  4. Helicobacter pylori’s potential association with epilepsy. Kountouras J, Deretzi G, Zavos C, Gavalas E, Polyzos SA, Klonizakis P, Tsiptsios D, Katsinelos P, Vardaka E, Tsiaousi E, Tsona A. Seizure. 2011 Oct 24. [Epub ahead of print]
  5. Serum vitamin B12 and folate levels in patients with nonalcoholic fatty liver disease. Polyzos SA, Kountouras J, Patsiaoura K, Katsiki N, Zafeiriadou, Zavos C, Deretzi G, Tsiaousi E, Slavakis Int J Food Sci Nutr .
  6. A potential impact of chronic Helicobacter pylori infection on  Alzheimer’s disease pathobiology and course. Kountouras J, Boziki M, Zavos C, Gavalas E, Giartza-Taxidou E, Venizelos I, Deretzi G, Grigoriadis N, Tsiaousi E, Vardaka E. Neurobiol Aging. 2012 [Epub ahead of print]
  7. Potential oncogenic properties of mobilized stem cells in a subpopulation of inflammatory bowel disease patients infected with Helicobacter pylori. Kapetanakis N, Kountouras J, Zavos C, Anastasiadou K, Tsarouchas G, Michael S, Gavalas E, Tsiaousi E, Polyzos SA, Venizelos I, Nikolaidou C, Vardaka E. Inflamm Bowel Dis. 2012 doi: 10.1002/ibd.22911. [Epub ahead of print].
  8. Potential implications of Helicobacter pylori-related neutrophil-activating protein. Kountouras J, Zavos C, Deretzi G, Gavalas E, Chatzopoulos D, Katsinelos P, Tsiaousi E, Gagalis S, Polyzos SA, Venizelos I. World J Gastroenterol. 2012;18(5):489-90
  9. Low aqueous humor ghrelin levels in open-angle glaucoma patients may correlate with Helicobacter pylori-associated apoptotic mechanisms. Zavos Ch, Kountouras J, Katsinelos P, Stergios AP, Deretzi G, Zavos N, Gavalas E, Tsiaousi E, Giartza-Taxidou E, Tzilves D, Arapoglou S. Hippokratia. 2011 Jul;15(3):287-8.
  10. Re: Helicobacter pylori infection and colorectal cancer risk: evidence from a large population-based case-control study in Germany. Kapetanakis N, Kountouras J, Zavos C, Michael S, Tsarouchas G, Gavalas E, Anastasiadou K, Tsiaousi E, Venizelos I, Nikolaidou C, Vardaka E, Kouklakis G, Moschos I. Am J Epidemiol. 2012 Sep 15;176(6):566-7
  11. Helicobacter pylori infection might contribute to esophageal adenocarcinoma progress in subpopulations with gastroesophageal reflux disease and Barrett’s esophagus. Kountouras J, Chatzopoulos D, Zavos C, Polyzos SA, Giartza-Taxidou E, Vardaka E, Molyvas E, Kouklakis G, Tsiaousi E, Klonizakis P. Helicobacter. 2012 Oct;17(5):402-3. doi: 10.1111/j.1523-5378.2012.00963.x.
  12. Adverse effects of smoking in ulcerative colitis. Kountouras J, Tsiaousi E, Zavos C. J Crohns Colitis. 2012 Sep 25. doi:pii: S1873-9946(12)00413-8. 10.1016/j.crohns.2012.09.012. [Epub ahead of print]
  13. Relationship between Helicobacter pylori infection and autoimmune disorders. Kountouras J, Zavos C, Polyzos SA, Michael S, Tsiaousi E, Vardaka E, Katsinelos P, Kouklakis G, Paikos D, Gavalas E, Deretzi G, Giartza-Taxidou E, Loli E. Clin Chem Lab Med. 2012 Dec 25:1-2. doi: 10.1515/cclm-2012-0753. [Epub ahead of print]
  14. Letter: is Helicobacter pylori behind Barrett’s oesophagus and colorectal neoplasms? Kountouras J, Zavos C, Chatzopoulos D, Romiopoulos I, Polyzos SA, Kapetanakis N, Tsiaousi E, Vardaka E, Deretzi G, Tsarouchas G, Katsinelos P. Aliment Pharmacol Ther. 2013 Apr;37(8):837. doi: 10.1111/apt.12247.
  15. Impact of Helicobacter pylori Infection on colon oncogenesis. Kountouras J, Kapetanakis N, Zavos C, Romiopoulos I, Polyzos SA, Tsiaousi E, Michael S, Vardaka E, Nikolaidou C, Venizelos I, Katsinelos P. Am J Gastroenterol. 2013 Apr;108(4):625-6. doi: 10.1038/ajg.2013.17.
  16. Is Helicobacter pylori the usual suspect behind gastroesophageal reflux disease and dacryostenosis? Kountouras J, Zavos C, Polyzos SA, Romiopoulos I, Stergiopoulos C, Tsiaousi E, Deretzi G, Giartza-Taxidou E, Vardaka E, Loli E, Kountouras C, Katsinelos P. Med Hypotheses. 2013 Jul;81(1):147. doi: 10.1016/j.mehy.2013.03.040. Epub 2013 Apr 30.
  17. Aquaporin 4, Helicobacter pylori and potential implications for neuromyelitis optica. Kountouras J, Deretzi G, Gavalas E, Zavos C, Boziki M, Tsiaousi E, Stergiopoulos C, Romiopoulos I, Giorgakis N, Michael S, Tantsi N, Kotsani M. J Neuroimmunol. 2013 Jul 5. doi:pii: S0165-5728(13)00162-8. 10.1016/j.jneuroim.2013.06.003.
  18. Trimebutine as a potential antimicrobial agent: a preliminary in vitro approach. Kountouras J, Sofianou D, Gavalas E, Sianou E, Zavos C, Meletis G, Tsiaousi E. Hippokratia. 2012 Oct;16(4):347-9.
  19. Prevalence of Barrett’s esophagus in Northern Greece: A Prospective Study (Barrett’s esophagus). Katsinelos P, Lazaraki G, Kountouras J, Chatzimavroudis G, Zavos C, Terzoudis S, Tsiaousi E, Gkagkalis S, Trakatelli C, Bellou A, Vasiliadis T. Hippokratia. 2013 Jan;17(1):27-33
  20. Helicobacter pylori might contribute to cancer and/or bone marrow-derived stem cell-related gastrointestinal oncogenesis. Kountouras J, Kapetanakis N, Zavos C, Polyzos SA, Romiopoulos I, Tsiaousi E, Anastasiadou K, Giorgakis N, Vardaka E, Nikolaidou C, Venizelos I, Katsinelos P. Oncogene. 2015 Jan 29;34(5):670. doi: 10.1038/onc.2013.602.
  21. Helicobacter pylori might contribute to nonalcoholic fatty liver disease-related cardiovascular events by releasing prothrombotic and proinflammatory factors. Kountouras J, Polyzos SA, Zavos C, Deretzi G, Kountouras C, Vardaka E, Katsinelos P, Tsiaousi E, Grigoriadis N, Romiopoulos I, Tzilves D, Giartza-Taxidou E. Hepatology. 2014 Oct;60(4):1450-1. doi: 10.1002/hep.27168.
  22. Helicobacter pylori-related metabolic syndrome might justify earlier colorectal cancer screening. Romiopoulos I, Kountouras J, Polyzos SA, Zavos C, Kapetanakis N, Deretzi G, Vardaka E, Kountouras C, Tsiaousi E, Anastasiadou K, Giorgakis N, Boura P, Katsinelos P. Gastrointest Endosc. 2014 Jul;80(1):188-9. doi: 10.1016/j.gie.2014.01.054.
  23. Helicobacter pylori infection in a Greek cohort with biliary disease. Kountouras J, Tsiaousi E, Trigonis S, Zavos C, Kouklakis G. Br J Biomed Sci. 2014;71(4):178-9
  24. Comment on “The correlation of Helicobacter pylori with the development of cholelithiasis and cholecystitis: the results of a prospective clinical study in Saudi Arabia”. Kountouras J, Tsiaousi E, Trigonis S, Polyzos SA, Katsinelos P, Zavos C, Vardaka E, Kountouras C, Gavalas E, Anastasiadou K, Vlachaki E, Boziki M, Zeglinas C, Venizelos I, Deretzi G. Eur Rev Med Pharmacol Sci. 2016;20(1):3-4.
  25. Helicobacter pylori infection and oesophageal adenocarcinoma. Kountouras J, Polyzos SA, Zeglinas C, Katsinelos P, Giorgakis N, Vardaka E, Kountouras C, Artemaki F, Tzivras D, Kazakos E, Tsiaousi E, Deretzi G Cancer Epidemiol. 2016 Jun;42:206-7. doi: 10.1016/j.canep.2016.04.005.
  26. Helicobacter pylori on portal hypertension-related hepatic encephalopathy. Kountouras J, Polyzos SA, Katsinelos P, Tzivras D, Boziki M, Gavalas E, Zavos C, Vardaka E, Romiopoulos I, Anastasiadis S, Tsiaousi E, Kountouras C, Xiromerisiou G, Deretzi G. Immunopharmacol Immunotoxicol. 2017 Apr;39(2):105-106. Doi:1080/08923973.2017.1286503. Epub 2017 Feb 10

Postdoctorale opleidingen

  1. 25th European Workshop on Gastroenterology and Endotherapy (Brussels June 2007)
  2. Advanced training course of Upper GI Bleeding/Bilio-Pancreatic stending. (Rome September 2007)
  3. 27th European Workshop on Gastroenterology and Endotherapy (Brussels June 2007)
  4. 29th European Workshop on Gastroenterology and Endotherapy (Brussels June 2009)
  5. Clinical Observation Programme University Hospital Leuven with Paul Rutgeerts MD, PhD, FRCP. (Leuven, Belgium February 2011)
  6. 4th school of clinical hepatology 2010-2011. Greek society of the study of the liver. Athens-Thessaloniki 2010-2011.